By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GW Pharmaceuticals Ltd. 

Porton Down Science Park

Salisbury  Wiltshire  SP4 0JQ  United Kingdom
Phone: 44-1980-619000 Fax: +44-1980-619111



Company News
Marijuana-Based Drug Helps Kids With Rare Forms Of Epilepsy In Studies, GW Pharma (GWPH) Reveals 6/28/2016 6:50:04 AM
GW Pharma (GWPH)’s Epidiolex Meets Primary Endpoint in Phase III 6/27/2016 6:24:05 AM
Cannabis Science Inc. Moves Forward Clinical Drug Development With Confidence As GW Pharma (GWPH) Announces Positive Results With Its CBD-Based Epilepsy Formulation 3/15/2016 10:58:02 AM
GW Pharma (GWPH) Shares Double as Cannabis Drug Meets Goals in Phase III Study 3/14/2016 6:03:51 AM
GW Pharma (GWPH) Reports First Quarter 2016 Financial Results And Operational Progress 2/10/2016 9:23:40 AM
GW Pharma (GWPH) To Present At The Leerink Partners 5th Annual Global Healthcare Conference 2/4/2016 12:13:50 PM
GW Pharma (GWPH) Release: The Lancet Neurology Publishes Data From The Epidiolex Expanded Access Program In Children And Young Adults With Treatment-Resistant Epilepsy 12/28/2015 9:16:49 AM
GW Pharma (GWPH) Announces New Physician Reports Of Epidiolex Treatment Effect In Children And Young Adults With Treatment-Resistant Epilepsy 12/7/2015 2:31:29 PM
GW Pharma (GWPH) Announces Date And Time Change For Q4 And Year-End 2015 Financial Results And Conference Call 11/30/2015 8:33:02 AM
GW Pharma (GWPH) Release: New Epidiolex (CBD) Data Accepted For Presentation At The 69th Annual Meeting Of The American Epilepsy Society 11/25/2015 7:56:29 AM